HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy Hamel Selected Research

Ribonuclease III (RNase III)

7/2014Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
1/2012Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
1/2011DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nancy Hamel Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 02/2004
5Breast Neoplasms (Breast Cancer)
09/2021 - 02/2003
3Prostatic Neoplasms (Prostate Cancer)
02/2013 - 02/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2009
2Hypersensitivity (Allergy)
01/2019 - 04/2013
2Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 04/2013
2Pleuropulmonary blastoma
01/2012 - 01/2011
1Goiter
01/2020
1Neurilemmoma (Schwannoma)
01/2020
1Schwannomatosis
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2018
1Subcutaneous panniculitis-like T-cell lymphoma
12/2018
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
12/2018
1Angiomyolipoma
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Tuberous Sclerosis (Bourneville's Disease)
01/2018
1autosomal recessive Candidiasis familial chronic mucocutaneous
04/2016
1Candidiasis (Moniliasis)
04/2016
1Lymphoma (Lymphomas)
04/2016
1Mycoses (Diseases, Fungus)
04/2016
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2016
1Microcephaly
04/2013
1Sertoli-Leydig Cell Tumor
01/2012
1Adenocarcinoma
08/2011
1Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2011
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2010
1Chronic Disease (Chronic Diseases)
04/2009
1medullary Thyroid cancer
03/2004

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
04/2016 - 02/2004
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2007
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2009
3Ribonuclease III (RNase III)IBA
07/2014 - 01/2011
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 01/2017
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2012
2Messenger RNA (mRNA)IBA
01/2020 - 08/2011
2EndoribonucleasesIBA
01/2012 - 01/2011
1Circulating Tumor DNAIBA
09/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
12/2018
1Mucin-3IBA
12/2018
1trans-sodium crocetinate (crocetin)IBA
01/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2016
1ras-GRF1 (ras GRF1)IBA
04/2016
1Oncogene Proteins (Oncogene Protein)IBA
02/2013
1Ribonucleases (Ribonuclease)IBA
01/2012
1GemcitabineFDA Link
08/2011
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
08/2011
1imidazole mustard (BIC)IBA
11/2009
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2009
1Checkpoint Kinase 2IBA
08/2008
1PhosphopeptidesIBA
07/2008
1Scavenger Receptors (Scavenger Receptor)IBA
02/2005
1ThyroglobulinFDA Link
03/2004
1Cyclin D1IBA
02/2004
1Cyclin EIBA
02/2004
1Keratin-5 (Keratin 5)IBA
02/2004
1Estrogen ReceptorsIBA
02/2004

Therapy/Procedure

2Therapeutics
01/2017 - 08/2011
2Drug Therapy (Chemotherapy)
04/2013 - 02/2003
1Adjuvant Chemotherapy
02/2003